{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:37:37Z","timestamp":1771479457809,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.tranon.2022.101614","type":"journal-article","created":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T04:12:57Z","timestamp":1672287177000},"page":"101614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Expression of glucose transporter-1 in follicular lymphoma affected tumor-infiltrating immunocytes and was related to progression of disease within 24 months"],"prefix":"10.1016","volume":"28","author":[{"given":"Yuwei","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8116-5293","authenticated-orcid":false,"given":"Qingyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2022.101614_bib0001","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-019-0132-x","article-title":"Follicular lymphoma","volume":"5","author":"Carbone","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"12","key":"10.1016\/j.tranon.2022.101614_bib0002","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1158\/1078-0432.CCR-13-1597","article-title":"EZH2 mutations in follicular lymphoma from different ethnic groups and associated gene expression alterations","volume":"20","author":"Guo","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"14","key":"10.1016\/j.tranon.2022.101614_bib0003","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood-2018-08-822148","article-title":"How I treat early-relapsing follicular lymphoma","volume":"133","author":"Casulo","year":"2019","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.tranon.2022.101614_bib0004","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1200\/JCO.2014.59.7534","article-title":"Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: an analysis from the national LymphoCare study","volume":"33","author":"Casulo","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2022.101614_bib0005","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ajh.25696","article-title":"Follicular lymphoma: 2020 update on diagnosis and management","volume":"95","author":"Freedman","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"9","key":"10.1016\/j.tranon.2022.101614_bib0006","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Pastore","year":"2015","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2022.101614_bib0007","article-title":"FDG-PET scan: a new paradigm for follicular lymphoma management","volume":"9","author":"Gallamini","year":"2017","journal-title":"Med. J. Hematol. Infect. Dis."},{"issue":"14","key":"10.1016\/j.tranon.2022.101614_bib0008","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.19.00010","article-title":"AUGMENT: a phase iii study of lenalidomide plus rituximab versus placebo plus rituximab in relapsed or refractory indolent Lymphoma","volume":"37","author":"Leonard","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"19","key":"10.1016\/j.tranon.2022.101614_bib0009","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1158\/0008-5472.CAN-18-1367","article-title":"Diverse functions of macrophages in different tumor microenvironments","volume":"78","author":"Yang","year":"2018","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.tranon.2022.101614_bib0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.immuni.2019.06.017","article-title":"Treg cells promote the srebp1-dependent metabolic fitness of tumor-promoting macrophages via repression of CD8(+) T Cell-derived interferon-gamma","volume":"51","author":"Liu","year":"2019","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.tranon.2022.101614_bib0011","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.tranon.2022.101614_bib0012","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40425-018-0493-9","article-title":"alpha-PD-1 therapy elevates Treg\/Th balance and increases tumor cell pSmad3 that are both targeted by alpha-TGFbeta antibody to promote durable rejection and immunity in squamous cell carcinomas","volume":"7","author":"Dodagatta-Marri","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.tranon.2022.101614_bib0013","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1002\/jcp.27782","article-title":"CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review","volume":"234","author":"Farhood","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"4","key":"10.1016\/j.tranon.2022.101614_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153550","article-title":"Anti-CD47 treatment stimulates phagocytosis of glioblastoma by M1 and M2 polarized macrophages and promotes M1 polarized macrophages in vivo","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.tranon.2022.101614_bib0015","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.cmet.2018.07.009","article-title":"Translating in vitro T cell metabolic findings to in vivo tumor models of nutrient competition","volume":"28","author":"Ecker","year":"2018","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.tranon.2022.101614_bib0016","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the intersections between metabolism and cancer biology","volume":"168","author":"Heiden","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.tranon.2022.101614_bib0017","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41419-019-1475-7","article-title":"Intracellular citrate accumulation by oxidized ATM-mediated metabolism reprogramming via PFKP and CS enhances hypoxic breast cancer cell invasion and metastasis","volume":"10","author":"Peng","year":"2019","journal-title":"Cell Death Dis."},{"issue":"13","key":"10.1016\/j.tranon.2022.101614_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133374","article-title":"Glut 1 in cancer cells and the inhibitory action of resveratrol as a potential therapeutic strategy","volume":"20","author":"Zambrano","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.tranon.2022.101614_bib0019","doi-asserted-by":"crossref","first-page":"8586","DOI":"10.1038\/s41598-019-44661-x","article-title":"The ion channels and transporters gene expression profile indicates a shift in excitability and metabolisms during malignant progression of Follicular Lymphoma","volume":"9","author":"Magi","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.tranon.2022.101614_bib0020","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1038\/s41467-019-12384-2","article-title":"Modulation of M2 macrophage polarization by the crosstalk between Stat6 and Trim24","volume":"10","author":"Yu","year":"2019","journal-title":"Nat. Commun."},{"issue":"7562","key":"10.1016\/j.tranon.2022.101614_bib0021","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nature14468","article-title":"T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection","volume":"523","author":"McKinney","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.tranon.2022.101614_bib0022","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1038\/s41467-019-13587-3","article-title":"miRNA142-3p targets Tet2 and impairs Treg differentiation and stability in models of type 1 diabetes","volume":"10","author":"Scherm","year":"2019","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.tranon.2022.101614_bib0023","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1159\/000460505","article-title":"MicroRNA-218 increases the sensitivity of bladder cancer to cisplatin by targeting glut1","volume":"41","author":"Li","year":"2017","journal-title":"Cell Physiol. Biochem."},{"issue":"5","key":"10.1016\/j.tranon.2022.101614_bib0024","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1073\/pnas.1612920114","article-title":"COX2\/mPGES1\/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells","volume":"114","author":"Prima","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7655","key":"10.1016\/j.tranon.2022.101614_bib0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature22396","article-title":"PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity","volume":"545","author":"Gordon","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2022.101614_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8586354","article-title":"Tumor microenvironment in diffuse large B-cell lymphoma: role and prognosis","volume":"2019","author":"Cioroianu","year":"2019","journal-title":"Anal. Cell Pathol."},{"issue":"4","key":"10.1016\/j.tranon.2022.101614_bib0027","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.cell.2017.04.004","article-title":"Metabolic Instruction of Immunity","volume":"169","author":"Buck","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.tranon.2022.101614_bib0028","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1158\/0008-5472.CAN-18-2545","article-title":"Tumor-associated macrophages enhance tumor hypoxia and aerobic glycolysis","volume":"79","author":"Jeong","year":"2019","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.tranon.2022.101614_bib0029","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1111\/cas.14078","article-title":"Tumor-associated macrophages promote bladder tumor growth through PI3K\/AKT signal induced by collagen","volume":"110","author":"Qiu","year":"2019","journal-title":"Cancer Sci."},{"issue":"486","key":"10.1016\/j.tranon.2022.101614_bib0030","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aal4186","article-title":"TGF-beta promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85alpha","volume":"10","author":"Hamidi","year":"2017","journal-title":"Sci. Signal"},{"issue":"5","key":"10.1016\/j.tranon.2022.101614_bib0031","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/s41375-019-0677-4","article-title":"The therapeutic effectiveness of (177)Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2\/M cell cycle arrest","volume":"34","author":"Pichard","year":"2020","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.tranon.2022.101614_bib0032","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/bjh.15656","article-title":"Differential expression of long non-coding RNAs are related to proliferation and histological diversity in follicular lymphomas","volume":"184","author":"Roisman","year":"2019","journal-title":"Br. J. Haematol."},{"issue":"12","key":"10.1016\/j.tranon.2022.101614_bib0033","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1182\/bloodadvances.2020004051","article-title":"Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma","volume":"5","author":"Nath","year":"2021","journal-title":"Blood Adv."},{"issue":"12","key":"10.1016\/j.tranon.2022.101614_bib0034","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic reprogramming and epigenetic modifications on the path to cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Protein Cell"},{"issue":"3","key":"10.1016\/j.tranon.2022.101614_bib0035","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41568-019-0106-z","article-title":"Immune control by amino acid catabolism during tumorigenesis and therapy","volume":"19","author":"Lemos","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2022.101614_bib0036","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cmet.2019.06.001","article-title":"Macrophages and metabolism in the tumor microenvironment","volume":"30","author":"Vitale","year":"2019","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.tranon.2022.101614_bib0037","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s13046-019-1409-3","article-title":"Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy","volume":"38","author":"Yin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.tranon.2022.101614_bib0038","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1158\/0008-5472.CAN-12-1969","article-title":"MEK1\/2 inhibition decreases lactate in BRAF-driven human cancer cells","volume":"73","author":"Miniotis","year":"2013","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.tranon.2022.101614_bib0039","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12967-017-1258-9","article-title":"Regulation of glucose uptake in lymphoma cell lines by c-MYC- and PI3K-dependent signaling pathways and impact of glycolytic pathways on cell viability","volume":"15","author":"Broecker-Preuss","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.tranon.2022.101614_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108796","article-title":"BAFF promotes T cell activation through the BAFF-BAFF-R-PI3K-Akt signaling pathway","volume":"114","author":"Hu","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.tranon.2022.101614_bib0041","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ajh.25711","article-title":"Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2-year follow-up of the CHRONOS-1 study","volume":"95","author":"Dreyling","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.tranon.2022.101614_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172425","article-title":"Metformin inhibits PPARdelta agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cells","volume":"857","author":"Ding","year":"2019","journal-title":"Eur. J. Pharmacol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193652332200273X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193652332200273X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T17:34:19Z","timestamp":1725816859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193652332200273X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":42,"alternative-id":["S193652332200273X"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2022.101614","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of glucose transporter-1 in follicular lymphoma affected tumor-infiltrating immunocytes and was related to progression of disease within 24 months","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2022.101614","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101614"}}